Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive crawled time : 13:00 save search
ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
Published: 2024-04-22 (Crawled : 13:00) - globenewswire.com
ASLN | News | $0.4645 2.09% 2.05% 1.5M
|
Health Technology
|
| O: 13.73%
H: 5.17%
C: -20.69%
dermatitis positive pharmaceuticals results study
NeuroSense Presents Positive Data Validating Phase 2b Topline Readout During Emerging Science Presentation at the American Academy of Neurology Annual Meeting
Published: 2024-04-18 (Crawled : 13:00) - neurosense.investorroom.com
NRSN | News | $1.35 -6.77% 79K
|
|
| O: -0.63%
H: 1.89%
C: -4.4%
neurology presentation readout positive topline meeting
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
Published: 2024-04-16 (Crawled : 13:00) - globenewswire.com
MYGN | $18.595 0.57% 0.56% 510K
|
Health Technology
|
| O: -2.61%
H: 0.0%
C: 0.0%
prequel positive for study
Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
|
| O: 4.48%
H: 0.82%
C: -2.05%
narcolepsy positive topline results study
Edible Garden Transitions Business to Edible Garden Heartland on Schedule; Increased Efficiency and Owned Facility Expected to Positively Impact Margins
Published: 2024-04-03 (Crawled : 13:00) - globenewswire.com
EDBL | News | $6.46 71.81% 41.8% 2M
|
|
| O: -0.62%
H: 50.0%
C: 16.22%
business expected impact
Scripps nominates consumer research and data expert to company board position
Published: 2024-03-25 (Crawled : 13:00) - prnewswire.com
SSP | News | $3.79 1.88% 1.85% 1M
|
Consumer Services
|
| O: 0.72%
H: 10.86%
C: 8.86%
company research
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
Published: 2024-03-20 (Crawled : 13:00) - biospace.com/
PBYI | $5.12 -0.97% -0.98% 290K
|
Health Technology
|
| O: 2.33%
H: 7.73%
C: 6.7%
fda breast cancer hormone
Workhorse Strengthens Financial Position with Convertible Note Transaction
Published: 2024-03-19 (Crawled : 13:00) - globenewswire.com
WKHS | $0.1609 1.58% 1.55% 12M
|
Producer Manufacturing
|
| O: 1.77%
H: 0.59%
C: -3.36%
financial
BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure
Published: 2024-03-04 (Crawled : 13:00) - globenewswire.com
BCDA P | $0.3678 -2.56% 80K
|
Health Technology
|
| O: 0.03%
H: 1.72%
C: -21.53%
biomarker positive cell cardiamp heart therapy results
FirstService Residential Further Enhances Market Leadership Position in Florida
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
FSV | $153.36 0.81% 0.8% 60K
|
Finance
|
| O: 0.94%
H: 0.0%
C: -1.42%
market
Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and China
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
TNXP | $0.1574 1.29% 1.27% 1.6M
|
Health Technology
|
| O: 4.56%
H: 4.17%
C: 2.22%
japan positive pharmaceuticals china results study
Matinas BioPharma Provides Positive Outcomes Update on the MAT2203 Compassionate/Expanded Use Access Program, Including Multiple Patients with Complete Clinical Resolution
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
MTNB | $0.1815 0.83% -0.61% 770K
|
Health Technology
|
| O: 1.59%
H: 15.13%
C: 10.61%
mat2203 positive update biopharma
MoonLake Immunotherapeutics Announces Positive Feedback from both FDA and EMA on Regulatory Path for the Phase 3 Program of the Nanobody® sonelokimab (SLK) in Hidradenitis Suppurativa (HS)
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
MLTX | $43.24 5.41% 5.13% 580K
|
|
| O: 0.0%
H: 2.86%
C: 0.13%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.82%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
nanobody fda positive ema program
Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept “Tick-Kill” Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease
Published: 2024-02-22 (Crawled : 13:00) - globenewswire.com
TARS | $33.73 4.46% 4.27% 220K
|
Health Technology
|
| O: -0.43%
H: 6.07%
C: 5.13%
tp-05 disease positive topline trial results
La Rosa Acquires Seventh Real Estate Brokerage Franchisee with Revenue of $1.4 Million and Positive Cash Flow in 2023
Published: 2024-02-22 (Crawled : 13:00) - globenewswire.com
LRHC | $1.5981 1.15% 16K
|
n/a
|
| O: 266.52%
H: 13.87%
C: -43.27%
rosa million revenue positive flow
SinglePoint Inc Announces Enhanced Market Position and Path to Near-Term Profitability
Published: 2024-02-21 (Crawled : 13:00) - prnewswire.com
SING | $0.2053 19.5% -6.97% 1.1M
|
|
| O: 0.0%
H: 5.44%
C: -0.6%
market
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
Published: 2024-02-14 (Crawled : 13:00) - globenewswire.com
PRPH | $5.21 6.33% 5.95% 17K
|
Health Technology
|
| O: -0.3%
H: 2.96%
C: 2.55%
positive results
Tonix Pharmaceuticals Hosted KOL Webinar on Positive Phase 3 Fibromyalgia Trial for Tonmya™, Plans to File NDA for FDA Approval in Second Half of 2024
Published: 2024-02-14 (Crawled : 13:00) - globenewswire.com
TNXP | $0.1574 1.29% 1.27% 1.6M
|
Health Technology
|
| O: 5.61%
H: 3.54%
C: 3.54%
fda fibromyalgia approval positive pharmaceuticals trial
ToughBuilt Anticipates Positive Operating Cash Flow by Q3 2024
Published: 2024-02-13 (Crawled : 13:00) - globenewswire.com
TBLT | $2.79 1.46% 1.43% 150K
|
Consumer Non-Durables
|
| O: 2.63%
H: 0.51%
C: -24.79%
positive flow
authID Positions for Strong Growth in Biometric Identity Verification and Authentication with New Identity Domain Talent
Published: 2024-02-08 (Crawled : 13:00) - globenewswire.com
AUID | $6.985 -9.17% -10.09% 150K
|
Manufacturing
|
| O: -0.05%
H: 1.95%
C: -1.55%
authid growth
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.